MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202617081612 A) filed by Leksum LLC on July 02, 2026, for Extracellular Vesicles For Therapy.
Inventor includes Larsson, Lars.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: This disclosure provides a secretion centric therapy to overcome muscle wasting. Provided are mesenchymal stem cell secretion-based therapies to overcome muscle wasting due to: old age; as a consequence of immobilization (e.g., mobility restricted or paralytics administered); due to use of ventilators (e.g., in an ICU or long-term immobilization); in microgravity during long space flights; or, resulting from drug side effects (e.g., the use of weight loss drugs, chemotherapies, etc.). This disclosure further provides methods and compositions for modulating, including regulating or altering, the structure and function of diaphragm muscle cells and/or diaphragm muscle fibers in particular, and skeletal muscle in general. In certain embodiments extracellular vesicles are applied to patients affected by muscle wasting.
Disclaimer: Curated by HT Syndication.
